focus -WSS

focus

author：leisure time 2025-09-30 00:36:26 - browse：5378

Geoff Martha, CEO of Medtronic Courtesy Medtronic

As one of the largest and oldest medical device companies in the world, Medtronic has a foot in almost every clinical area.

The device maker with a market valuation of nearly $100 billion sells pacemakers, spinal cord stimulators, stents, monitors. Name a device, and they probably make it. The behemoth is ubiquitous in health care, but its size can make innovation sluggish. Medtronic has tried to become more streamlined in recent years — the company announced plans last year to spin off its patient monitoring and respiratory businesses, which Reuters recently reported, citing unnamed sources, may go to the Carlyle Group, a private equity firm.

Still, the device giant is immersed in many different specialties, including diabetes and high blood pressure, where the company has experienced some setbacks. Medtronic has sold old-school insulin pumps since the 1980s and therefore developed robust dosing algorithms, but has never successfully built a tubeless pump. The company plans to buy Korean patch pump maker EOFlow, but EOFlow is enmeshed in a patent battle with Insulet. A federal judge blocked EOFlow from selling its wearable patch pumps earlier this month.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： World's first CRISPR

focus

WSS

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

Eli Lilly CEO gives to Mike Pence presidential super PAC

FDA panel to weigh safety of artificial wombs for preterm births

Wegovy, Zepbound and weight loss drugs that preserve muscle

Astellas still sees hope in its gene therapy after four deaths

Congress must reauthorize a committee to support older Americans

knowledge

focus

hotspot

Affirmative action in medical school literally saved lives

PBMs drew scrutiny in House hearing — and so did pharma

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Eli Lilly CEO gives to Mike Pence presidential super PAC

DIEP, the 'gold standard' of breast reconstruction, is under threat

House panel takes first step toward fixing drug shortages

Hepatitis C has a cure — but many Americans still lack access to it

David Liu startup to focus on CRISPR delivery

Virginia high school admissions case could be legal follow

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

leisure time

Gain of function research would be limited under House proposal

PBM reforms clear House panel

Transgender sports debate: Physicians say bans are health issue

Patients, doctors press FTC to beef up hospital merger scrutiny

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

Hospitals look to new technology to keep health care workers safe

Wikipedia

focus

focus

entertainment